CIK 0001177648
- Non-accelerated filer
- Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- Operating
- EIN
- 043205099
- Phone
- +1 617-607-0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-03-04 | Golumbeski George Director | Sale | −9,280 | $103.65 | $962K | 0 |
| 2019-03-04 | Golumbeski George Director | Exercise or conversion · Stock Option (Right to Buy) | −9,280 | 0 | ||
| 2019-03-01 | Or Yat Sun Sr. VP & CSO | Sale | −5,910 | $103.32 | $611K | 304,763 |
| 2019-03-01 | Or Yat Sun Sr. VP & CSO | Sale | −4,090 | $103.84 | $425K | 300,673 |
| 2019-02-28 | Vance Terry Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2019-02-28 | Russell Lesley Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2019-02-28 | Peterson Kristine Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2019-02-28 | Golumbeski George Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2019-02-28 | CARTER BRUCE L A Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2019-02-28 | Buckley Stephen Jr. Director | Grant or award · Stock Option (right to buy) | +5,000 | 5,000 | ||
| 2019-02-13 | MELLETT PAUL J Treasurer and CFO | Exercise or conversion | +6,960 | $1.51 | $10K | 97,188 |
| 2019-02-13 | MELLETT PAUL J Treasurer and CFO | Exercise or conversion · Stock Option (right to buy) | −6,960 | 0 | ||
| 2019-02-13 | Gardiner Nathaniel S. Sr. VP & General Counsel | Sale | −3,270 | $95.28 | $312K | 23,978 |
| 2019-02-12 | Ocain Tim Senior Vice President | Grant or award | +4,000 | 12,127 | ||
| 2019-02-12 | Ocain Tim Senior Vice President | Grant or award | +10,000 | 22,127 | ||
| 2019-02-12 | Ocain Tim Senior Vice President | Shares withheld for taxes | −4,580 | $88.88 | $407K | 17,547 |
| 2019-02-12 | Adda Nathalie Sr. VP & Chief Medical Officer | Grant or award | +4,500 | 4,500 | ||
| 2019-02-12 | Adda Nathalie Sr. VP & Chief Medical Officer | Grant or award | +11,250 | 15,750 | ||
| 2019-02-12 | Adda Nathalie Sr. VP & Chief Medical Officer | Shares withheld for taxes | −5,356 | $88.88 | $476K | 10,394 |
| 2019-02-12 | Gardiner Nathaniel S. Sr. VP & General Counsel | Grant or award | +4,000 | 21,827 |
Page 23 of 31 · 619 trades